Literature DB >> 20154289

Molecular diversity of hemoglobin H disease in India.

Anita H Nadkarni1, Sona B Nair, Khushnooma Y Italia, Prashant Warang, Madhura Dalvi, Kanjaksha Ghosh, Roshan B Colah.   

Abstract

This study was undertaken to evaluate the variable clinical expression of hemoglobin (Hb) H disease in India. For the study, alpha genotyping was done in 8 patients with Hb H disease using multiplex polymerase chain reaction and DNA sequencing. The study revealed that 4 genotypes (- -(SEA)/ -alpha(3.7), - -(SA)/-alpha(3.7), - -(SEA)/-alpha(3.7 Sallanches), - -alpha(3.7)/-alpha(3.7 Sallanches)) were responsible for Hb H disease, the alpha+ thalassemia mutation (-alpha(3.7) deletion) being the most common defect. The nondeletional mutation Hb Sallanches (alpha 2 codon 104 G --> A) was seen in 3 cases. Two unique and novel genotypes leading to Hb H disease were characterized (- -(SEA)/-alpha(3.7 Sallanches) and -alpha(3.7)/-alpha(3.7 Sallanches)). Because a majority of patients with Hb H disease do not have severe manifestations, prenatal diagnosis is usually unwarranted in India.

Entities:  

Mesh:

Year:  2010        PMID: 20154289     DOI: 10.1309/AJCP70ORBRURVSJM

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Reticulum vs Inclusions: A Learning Experience in Haemoglobin H Disease.

Authors:  Hanaganahalli B Sridevi; Anupama Hegde; Prashantha Balanthimogru; Urmila N Khadilkar; Shrijeet Chakraborti
Journal:  J Clin Diagn Res       Date:  2015-10-01

2.  Alpha thalassaemia in tribal communities of coastal Maharashtra, India.

Authors:  Madhav G Deo; Prakash V Pawar
Journal:  Indian J Med Res       Date:  2014-08       Impact factor: 2.375

3.  Mutation analysis of β-thalassemia in East-Western Indian population: a recent molecular approach.

Authors:  Parth S Shah; Nidhi D Shah; Hari Shankar P Ray; Nikunj B Khatri; Ketan K Vaghasia; Rutvik J Raval; Sandip C Shah; Mandava V Rao
Journal:  Appl Clin Genet       Date:  2017-05-11

4.  Significance of borderline HbA2 levels in β thalassemia carrier screening.

Authors:  Stacy Colaco; Roshan Colah; Anita Nadkarni
Journal:  Sci Rep       Date:  2022-03-30       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.